Yarema Kristin Insider Trades

Insider Trading History

Track insider trading activity for Yarema Kristin. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
ImageneBio
ImageneBio IMA
Chief Executive Officer
Holding Value $770k 128,100 shares
Last Trade
Mar 16, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.32M 213,500 shares
$6.20
$6.01
ImageneBio
ImageneBio IMA
Chief Executive Officer
Holding Value $2.77M 460,515 shares
Last Trade
Jul 28, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$6.01
Poseida Therapeutics
Poseida Therapeutics PSTX
President And CEO
Holding Value $0 0 shares
Last Trade
Jan 08, 2025 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$8.01M 843,525 shares
$9.50
$9.50
Poseida Therapeutics
Poseida Therapeutics PSTX
President And CEO
Holding Value $0 0 shares
Last Trade
Jan 08, 2025 Sale (Tender)Reported as Tender on SEC Form 4.
$5.54M 615,836 shares
$9.00
$9.50
Poseida Therapeutics
Poseida Therapeutics PSTX
President And CEO
Holding Value $5.76M 606,836 shares
Last Trade
Jan 02, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.17M 345,200 shares
$3.38
$9.50
Poseida Therapeutics
Poseida Therapeutics PSTX
President, Cell Therapy
Holding Value $4.73M 498,325 shares
Last Trade
Apr 11, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.31M 498,325 shares
$2.62
$9.50
Atara Biotherapeutics
Atara Biotherapeutics ATRA
Director, Chief Commercial Officer
Holding Value $955k 85,592 shares
Last Trade
Mar 01, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$21.8M 85,592 shares
$255.25
$11.16
Atara Biotherapeutics
Atara Biotherapeutics ATRA
Chief Commercial Officer
Holding Value $1.4M 125,882 shares
Last Trade
Jun 14, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$11.9M 32,333 shares
$366.50
$11.16
Atara Biotherapeutics
Atara Biotherapeutics ATRA
Chief Commercial Officer
Holding Value $1.04M 93,549 shares
Last Trade
Jun 11, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$728k 2,021 shares
$360.00
$11.16
Atara Biotherapeutics
Atara Biotherapeutics ATRA
Chief Commercial Officer
Holding Value $1.02M 91,528 shares
Last Trade
May 18, 2021 Sale (Open Market)Shares sold on the open market or in a private sale.
$276k 761 shares
$363.25
$11.16
Atara Biotherapeutics
Atara Biotherapeutics ATRA
Chief Commercial Officer
Holding Value $1.03M 92,289 shares
Last Trade
Mar 01, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$22.6M 52,862 shares
$427.63
$11.16
Atara Biotherapeutics
Atara Biotherapeutics ATRA
Chief Commercial Officer
Holding Value $614k 55,000 shares
Last Trade
Mar 01, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$16.7M 55,000 shares
$303.75
$11.16
Atara Biotherapeutics
Atara Biotherapeutics ATRA
Chief Commercial Officer
Holding Value $1.23M 110,000 shares
Last Trade
Feb 18, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$40M 110,000 shares
$363.88
$11.16

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up